Re-Staging Following Long-Course Chemoradiotherapy For Rectal Cancer: Does It Influence Management?

A McBrearty1, K McCallion1, R J Moorehead1

  • 1Department of General Surgery, Ulster Hospital, Dundonald, Belfast, BT16 1RH.

Summary

Restaging rectal cancer patients after long-course chemoradiotherapy (LCCRT) significantly alters management plans for 32% of patients. This restaging, using CT and MRI, helps avoid unnecessary surgery in many cases.